Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.36 is 60% above its 5-year average of -3.41, near the high end of its 5-year range (-5.57–-1.36).
10.82% above its 12-month average of -1.52.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.47.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.36
EARNINGS PER SHARE (EPS) AVG TTM
-1.52
EARNINGS PER SHARE (EPS) AVG 3Y
-3.10
EARNINGS PER SHARE (EPS) AVG 5Y
-3.41
EARNINGS PER SHARE (EPS) AVG 10Y
-2.76
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+10.82%
CURRENT VS 3Y AVG
+56.13%
CURRENT VS 5Y AVG
+60.10%
CURRENT VS 10Y AVG
+50.71%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Natera, Inc.
Market Cap
$58.77B
Earnings Per Share (EPS)
-1.36
TTM Avg
-1.52
3Y Avg
-3.10
5Y Avg
-3.41
Market Cap
$60.13B
Earnings Per Share (EPS)
13.46
TTM Avg
7.81
3Y Avg
8.10
5Y Avg
3.88
Market Cap
$63.32B
Earnings Per Share (EPS)
2.46
TTM Avg
1.61
3Y Avg
1.19
5Y Avg
1.09
Market Cap
$53.47B
Earnings Per Share (EPS)
7.23
TTM Avg
6.88
3Y Avg
4.62
5Y Avg
2.87
Market Cap
$49.03B
Earnings Per Share (EPS)
1.74
TTM Avg
4.41
3Y Avg
3.40
5Y Avg
2.89
Market Cap
$48.72B
Earnings Per Share (EPS)
3.32
TTM Avg
5.86
3Y Avg
5.65
5Y Avg
5.38
Market Cap
$47.38B
Earnings Per Share (EPS)
5.08
TTM Avg
4.52
3Y Avg
4.36
5Y Avg
3.96
Market Cap
$46.63B
Earnings Per Share (EPS)
10.56
TTM Avg
9.94
3Y Avg
15.54
5Y Avg
18.41
Market Cap
$71.48B
Earnings Per Share (EPS)
24.16
TTM Avg
17.27
3Y Avg
18.45
5Y Avg
18.81
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Natera, Inc. (NTRA) | $58.77B | -1.36 | -1.52 | -3.10 | -3.41 |
| Cencora, Inc. (COR)vs › | $60.13B | 13.46 | 7.81 | 8.10 | 3.88 |
| Boston Scientific Corporation (BSX)vs › | $63.32B | 2.46 | 1.61 | 1.19 | 1.09 |
| Cardinal Health, Inc. (CAH)vs › | $53.47B | 7.23 | 6.88 | 4.62 | 2.87 |
| Edwards Lifesciences Corporation (EW)vs › | $49.03B | 1.74 | 4.41 | 3.40 | 2.89 |
| Becton, Dickinson and Company (BDX)vs › | $48.72B | 3.32 | 5.86 | 5.65 | 5.38 |
| Agilent Technologies, Inc. (A)vs › | $47.38B | 5.08 | 4.52 | 4.36 | 3.96 |
| Humana Inc. (HUM)vs › | $46.63B | 10.56 | 9.94 | 15.54 | 18.41 |
| Cigna Corporation (CI)vs › | $71.48B | 24.16 | 17.27 | 18.45 | 18.81 |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $46.04B | 0.60 | -0.11 | -0.73 | -1.03 |
Trailing EPS (TTM)
$-1.36
Forward EPS (Est.)
$-1.39
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.52 |
| 2024-12-31 | -1.53 |
| 2023-12-31 | -3.78 |
| 2022-12-31 | -5.57 |
| 2021-12-31 | -5.21 |
| 2020-12-31 | -2.84 |
| 2019-12-31 | -1.79 |
| 2018-12-31 | -2.22 |
| 2017-12-31 | -2.56 |
| 2016-12-31 | -1.86 |
| 2015-12-31 | -1.47 |
| 2014-12-31 | -0.14 |
| 2013-12-31 | -1.01 |
| 2012-12-31 | -24.37 |
